Nature Communications (Jun 2023)

A viral pan-end RNA element and host complex define a SARS-CoV-2 regulon

  • Debjit Khan,
  • Fulvia Terenzi,
  • GuanQun Liu,
  • Prabar K. Ghosh,
  • Fengchun Ye,
  • Kien Nguyen,
  • Arnab China,
  • Iyappan Ramachandiran,
  • Shruti Chakraborty,
  • Jennifer Stefan,
  • Krishnendu Khan,
  • Kommireddy Vasu,
  • Franklin Dong,
  • Belinda Willard,
  • Jonathan Karn,
  • Michaela U. Gack,
  • Paul L. Fox

DOI
https://doi.org/10.1038/s41467-023-39091-3
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 22

Abstract

Read online

Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, generates multiple protein-coding, subgenomic RNAs (sgRNAs) from a longer genomic RNA, all bearing identical termini with poorly understood roles in regulating viral gene expression. Insulin and interferon-gamma, two host-derived, stress-related agents, and virus spike protein, induce binding of glutamyl-prolyl-tRNA synthetase (EPRS1), within an unconventional, tetra-aminoacyl-tRNA synthetase complex, to the sgRNA 3′-end thereby enhancing sgRNA expression. We identify an EPRS1-binding sarbecoviral pan-end activating RNA (SPEAR) element in the 3′-end of viral RNAs driving agonist-induction. Translation of another co-terminal 3′-end feature, ORF10, is necessary for SPEAR-mediated induction, independent of Orf10 protein expression. The SPEAR element enhances viral programmed ribosomal frameshifting, thereby expanding its functionality. By co-opting noncanonical activities of a family of essential host proteins, the virus establishes a post-transcriptional regulon stimulating global viral RNA translation. A SPEAR-targeting strategy markedly reduces SARS-CoV-2 titer, suggesting a pan-sarbecoviral therapeutic modality.